September 2020

ASCRS NEWS

Gene therapy


by Vance Thompson, MD Refractive Editor


Vance Thompson, MD Refractive Editor

It has been said that the eyes are the windows to our soul. The key to unlocking the full potential of our visual performance and health is gene therapy and genetic testing. In this issue of EyeWorld, I think you will enjoy learning how genetic medicine has moved beyond rare disease and is heading toward quality treatments for some of the world’s leading causes of blindness.
Genetic testing is a type of medical test that identifies changes in a patient’s chromosomes or genes. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person’s chance of developing a genetic disorder or passing it on to the next generation. There are many genetic tests currently in use, and more are being developed.
Gene therapy uses genes or genetic material (like nucleic acids) to treat or prevent disease.

There are many reasons the eye is ideal to study genetic testing and therapy, and in this issue, we are fortunate to have leading experts in this exciting arena to educate and update us. Thomas Ciulla, MD, and Elliott Sohn, MD, teach us how and why gene therapy is making so much progress in ophthalmology. Mitchell Jackson, MD, William Trattler, MD, and Elizabeth Yeu, MD, update us on the progress of genetic testing for keratoconus. Tara Moore, PhD, and Albert Jun, MD, take us deeper into exploring corneal genetics and gene editing. Finally, Kapil Bharti, PhD, David Gamm, MD, PhD, Ula Jurkunas, MD, and Elliott Sohn, MD, educate us on stem cell replacement therapies for the eye.
I think you will find these articles are a great way to educate and update yourself on the current status of genetic testing and gene therapy in the ophthalmology world today. Thank you to our wonderful group of doctors and the writers at EyeWorld who made this issue possible.

Gene therapy Gene therapy
Ophthalmology News - EyeWorld Magazine
283 110
283 110
,
2020-08-31T09:50:56Z
True, 9